Customizing Clinical Trials for Stakeholder Success Part 1: Setting the Stage for Designing Trials
In part one of this episode, Donovan Quill, Executive Vice President of Business Development, Growth & Strategy; Bob Gilkin, Senior Vice President of Trade and Specialty Strategy; and Andy Szczotka, AscellaHealth’s Chief Pharmacy Officer, discuss what payers are really looking for when it comes to clinical trials and the critical collaboration that’s needed early on between commercial teams and payers in designing clinical trials to improve workflows and pave the way for better patient access.
About AscellaHealth
Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.
We’re here to change that.
Because at AscellaHealth, we believe that all patients in need should have the ability to access life-changing therapies.
Our Core Beliefs
At AscellaHealth, patients are not just part of the process—they’re why we do what we do. Every solution we build and every partnership we form is designed with the patient in mind.
Patients First, Always.
Balancing Cost and Care.
Better Stakeholder Outcomes.